Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Protein measurement with the Folin phenol reagent.

LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ.

J Biol Chem. 1951 Nov;193(1):265-75. No abstract available.

2.

Glutathione reductase in red blood cells: variant associated with gout.

Long WK.

Science. 1967 Feb 10;155(3763):712-3.

PMID:
6017801
3.

Evidence against the existence of guanosine and inosine kinases in human fibroblasts in tissue culture.

Friedmann T, Seegmiller JE, Subak-Sharpe JH.

Exp Cell Res. 1969 Aug;56(2):425-9. No abstract available.

PMID:
5824460
4.

Biochemical bases of accelerated purine biosynthesis de novo in human fibroblasts lacking hypoxanthine-guanine phosphoribosyltransferase.

Rosenbloom FM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE.

J Biol Chem. 1968 Mar 25;243(6):1166-73. No abstract available.

5.

Purine base incorporation into erythrocyte nucleotides and erythrocyte phosphoribosyltransferase activity in primary gout.

Sperling O, Ophir R, de Vries A.

Rev Eur Etud Clin Biol. 1971 Feb;16(2):147-51. No abstract available.

PMID:
5552535
6.

Effects of allopurinol and oxipurinol on purine synthesis in cultured human cells.

Kelley WN, Wyngaarden JB.

J Clin Invest. 1970 Mar;49(3):602-9.

7.

Relationships between glycogen storage disease and tophaceous gout.

Alepa FP, Howell RR, Klinenberg JR, Seegmiller JE.

Am J Med. 1967 Jan;42(1):58-66. No abstract available.

PMID:
5225563
8.

Electrophoretic characterization of human phosphoribosylpyrophosphate synthetase.

Boer P, Sperling O, De Vries A.

Biochem Med. 1974 Jun;10(2):175-9. No abstract available.

PMID:
4364466
10.

Erythrocyte adenine phosphoribosyltransferase in the Lesch-Nyhan syndrome.

Bashkin P, Sperling O, Schmidt R, Szeinberg A.

Isr J Med Sci. 1973 Nov-Dec;9(11):1553-8. No abstract available.

PMID:
4360289
13.

Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.

Sperling O, Persky-Brosh S, Boer P, De Vries A.

Biochem Med. 1973 Jun;7(3):389-95. No abstract available.

PMID:
4351826
14.

Human glutamine phosphoribosylpyrophosphate amidotransferase. Kinetic and regulatory properties.

Holmes EW, McDonald JA, McCord JM, Wyngaarden JB, Kelley WN.

J Biol Chem. 1973 Jan 10;248(1):144-50. No abstract available.

15.

Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.

Becker MA, Meyer LJ, Wood AW, Seegmiller JE.

Science. 1973 Mar 16;179(4078):1123-6.

PMID:
4347565
16.

Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production.

Sperling O, Boer P, Persky-Brosh S, Kanarek E, De Vries A.

Rev Eur Etud Clin Biol. 1972 Aug-Sep;17(7):703-6. No abstract available.

PMID:
4346548
17.

Accelerated erythrocyte 5-phosphoribosyl-1-pyrophosphate synthesis. A familial abnormality associated with excessive uric acid production and gout.

Sperling O, Eilam G, Sara-Persky-Brosh, De Vries A.

Biochem Med. 1972 Aug;6(4):310-6. No abstract available.

PMID:
4340256
18.

Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties.

Fox IH, Kelley WN.

J Biol Chem. 1971 Sep 25;246(18):5739-48. No abstract available.

19.

Phosphoribosylpyrophosphate in man: biochemical and clinical significance.

Fox IH, Kelley WN.

Ann Intern Med. 1971 Mar;74(3):424-33. Review. No abstract available.

PMID:
4324023
20.

Repression and derepression of purine biosynthesis in mammalian hepatoma cells in culture.

Martin DW Jr, Owen NT.

J Biol Chem. 1972 Sep 10;247(17):5477-85. No abstract available.

Supplemental Content

Support Center